SEARCH: Sciumè ', NMS FOR DEVELOPMENT AND OPENING A NEW MEMBERS
(AGI) - Milan, March 15 - End of the restructuring by the middle 'of May, completing the reorganization of the group by opening a third capital, no cuts in human resources, conditions permitting. These according to the route outlined by the President of Nerviano Medical Sciences, Albert Sciumè ', the road map for revitalizing the group at the center of attention after the difficulties' that characterized 2009.
On the sidelines of a roundtable discussion that addressed the issues of Milan in cancer research and clinical trials, Sciumè 'recalled the efforts made to explain the implementation of a "major operation which will see' even on the budgets of the group 'cause he led to the satisfactory outcome of a cost reduction equal to 37-40%. In the near future, therefore, the will '"to define the passage of restructuring that we hope will be completed by the end of April-meta' in May, especially with regard to the agreements with Pfizer, which so far have weighed heavily on strategy." In terms of the reorganization, Sciumè 'noted the "need' to open a third capital, by bringing resources in terms of industrial partnership." Work in progress, therefore, also with regard to the property 'if, in fact, Nerviano Medical Science is 100% owned by the Congregation of the Sons of the Immaculate Conception, Sciumè' stressed that he had received a "mandate that includes a ' Opening substantial, that 'a reduction in the participation of the congregation in the majority. The strategy - he explained - and 'mainly linked to prospects of financial assistance to operators and which' should be given a draft of a financial nature ".
On the employment front, finally, orientation, and 'tericamento contrast to the contraction of' staff: "Our business plan over the medium term, ie in the years 2010-2012 - announced the president of NMS - dell'occupaizone expected to increase. Naturalemnte, provided that there are conditions. "(AGI) Cli / Car
Adapted from Agency Journalistic Italy
0 comments:
Post a Comment